Wolters Kluwer: Too many uncertainties despite an undemanding valuation

Goldman Sachs initiates coverage on Wolters Kluwer at Neutral with a €71 target price, citing structural AI risks and intensifying competition despite attractive valuation multiples.

Key Takeaways

• 1.Goldman Sachs initiates coverage on Wolters Kluwer with a Neutral rating and a €71 price target, seeing an undemanding valuation but few catalysts for re-rating.
• 2.WKL's AI Moat Score of 6.8 lags behind peer RELX (9.0), with concerns regarding the monetisation of AI products beyond retention.
• 3.Increased competition from AI-first disruptors like OpenEvidence is expected to decelerate growth in the Health Clinical Solutions segment to ~4%.

Table of Contents

• Our thesis in six charts
• Company overview
• How is Wolters positioned with AI?
• Financials: Stable top-line growth; below consensus
• Valuation: 12-month price target of €71 implies limited upside
• Health - Focus on Clinical Solutions given greater competition
• Tax - Growth likely to slow
• F&CC - What's inside?
• Legal & Regulatory- Debate on strength of the moat
• Key risks
• Summary financials
• Appendix - AI methodology
• Disclosure Appendix

Document Preview

Page 1 of 5

Subscribe for full accessStart Free Trial